BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2259304)

  • 1. Home heparin infusion in the management of deep vein thrombophlebitis.
    Mahmud K; Keenan JM; Bennett MB
    Minn Med; 1990 Nov; 73(11):31-3. PubMed ID: 2259304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous home heparin infusion therapy in the ambulatory patient.
    Homza SA
    J Intraven Nurs; 1991; 14(1):37-40. PubMed ID: 1846652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home treatment of deep vein thrombosis: a two-years experience of a single institution.
    Grau E; Real E; Pastor E; Viciano V; Aguiló J
    Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].
    Frank D; Blättler W
    Schweiz Med Wochenschr; 1998 Sep; 128(36):1328-33. PubMed ID: 9784675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.
    Bounameaux H; Ehringer H; Hulting J; Rasche H; Rapold HJ; Zultak M
    Thromb Haemost; 1997 Sep; 78(3):997-1002. PubMed ID: 9308743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-treatment of deep vein thrombosis in patients with cancer.
    Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
    Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous heparin infusion in the home-bound ambulatory patient using the Travenol Infusor: a descriptive report.
    Merrigan DM; Enriquez NC; Akahoshi MP
    NITA; 1987; 10(2):122-6. PubMed ID: 3645342
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home treatment of calf deep venous thrombosis.
    Callister CB; Wood SD; White GL; Tucker ED
    West J Med; 1991 Sep; 155(3):299-300. PubMed ID: 1949790
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of deep vein thrombosis of the lower extremity in pregnancy.
    Aburahma AF; Bastug DF; Tiley EH; Killmer SM; Boland JP
    W V Med J; 1993 Oct; 89(10):445-7. PubMed ID: 8266682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin.
    Smith BJ; Weekley JS; Pilotto L; Howe T; Beven R
    Intern Med J; 2002; 32(1-2):29-34. PubMed ID: 11783670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
    Lee M; Pao D; Hsu T; Sonderskov A
    Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B; Lundh B
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase or heparin in the management of patients with deep vein thrombosis?
    Kiil J; Carvalho A; Saksø P; Nielsen HO
    Acta Chir Scand; 1981; 147(7):529-32. PubMed ID: 7048826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
    Partsch H; Kechavarz B; Köhn H; Mostbeck A
    Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.